Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 151

1.

Expression of RNA-binding protein IMP3 (KOC) in benign urothelium and urothelial tumors.

Li L, Xu H, Spaulding BO, Cheng L, Simon R, Yao JL, di Sant'Agnese PA, Bourne PA, Huang J.

Hum Pathol. 2008 Aug;39(8):1205-11. doi: 10.1016/j.humpath.2007.12.012. Epub 2008 Jun 10.

PMID:
18547613
[PubMed - indexed for MEDLINE]
2.

IMP3 predicts aggressive superficial urothelial carcinoma of the bladder.

Sitnikova L, Mendese G, Liu Q, Woda BA, Lu D, Dresser K, Mohanty S, Rock KL, Jiang Z.

Clin Cancer Res. 2008 Mar 15;14(6):1701-6. doi: 10.1158/1078-0432.CCR-07-2039.

PMID:
18347170
[PubMed - indexed for MEDLINE]
Free Article
3.

Prognostic significance of atypical papillary urothelial hyperplasia.

Swierczynski SL, Epstein JI.

Hum Pathol. 2002 May;33(5):512-7.

PMID:
12094376
[PubMed - indexed for MEDLINE]
4.

[Molecular changes in development and progression of urothelial carcinoma].

Hartmann A.

Verh Dtsch Ges Pathol. 2003;87:172-84. Review. German.

PMID:
16888910
[PubMed - indexed for MEDLINE]
5.

IMP3 expression in urothelial carcinomas of the urinary bladder.

Ozdemir NO, Türk NS, Düzcan E.

Turk Patoloji Derg. 2011 Jan;27(1):31-7.

PMID:
21469424
[PubMed - indexed for MEDLINE]
Free Article
6.

High-grade neuroendocrine carcinomas of the lung express K homology domain containing protein overexpressed in cancer but carcinoid tumors do not.

Xu H, Bourne PA, Spaulding BO, Wang HL.

Hum Pathol. 2007 Apr;38(4):555-63. Epub 2007 Feb 20.

PMID:
17316760
[PubMed - indexed for MEDLINE]
7.

Expression of the multidrug resistance-associated protein (MRP) gene in urothelial carcinomas.

Kubo H, Sumizawa T, Koga K, Nishiyama K, Takebayashi Y, Chuman Y, Furukawa T, Akiyama S, Ohi Y.

Int J Cancer. 1996 Dec 20;69(6):488-94.

PMID:
8980253
[PubMed - indexed for MEDLINE]
8.

Insulin-like growth factor mRNA binding protein 3 (IMP3) is differentially expressed in benign and malignant follicular patterned thyroid tumors.

Slosar M, Vohra P, Prasad M, Fischer A, Quinlan R, Khan A.

Endocr Pathol. 2009 Fall;20(3):149-57. doi: 10.1007/s12022-009-9079-x.

PMID:
19449140
[PubMed - indexed for MEDLINE]
9.

The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.

Zheng W, Yi X, Fadare O, Liang SX, Martel M, Schwartz PE, Jiang Z.

Am J Surg Pathol. 2008 Feb;32(2):304-15. doi: 10.1097/PAS.0b013e3181483ff8.

PMID:
18223334
[PubMed - indexed for MEDLINE]
10.

IMP3 expression in lesions of the biliary tract: a marker for high-grade dysplasia and an independent prognostic factor in bile duct carcinomas.

Riener MO, Fritzsche FR, Clavien PA, Pestalozzi BC, Probst-Hensch N, Jochum W, Kristiansen G.

Hum Pathol. 2009 Oct;40(10):1377-83. doi: 10.1016/j.humpath.2009.01.024. Epub 2009 May 20.

PMID:
19467694
[PubMed - indexed for MEDLINE]
11.

Extrapulmonary small cell carcinomas express K homology domain containing protein overexpressed in cancer, but carcinoid tumors do not.

Simon R, Bourne PA, Yang Q, Spaulding BO, di Sant'Agnese PA, Wang HL, Xu H.

Hum Pathol. 2007 Aug;38(8):1178-83. Epub 2007 May 22.

PMID:
17521698
[PubMed - indexed for MEDLINE]
12.

Significance of denuded urothelium in papillary urothelial lesions.

Owens CL, Epstein JI.

Am J Surg Pathol. 2007 Feb;31(2):298-303.

PMID:
17255776
[PubMed - indexed for MEDLINE]
13.

Expression of a novel oncofetal mRNA-binding protein IMP3 in endometrial carcinomas: diagnostic significance and clinicopathologic correlations.

Li C, Zota V, Woda BA, Rock KL, Fraire AE, Jiang Z, Lu D, Xu B, Dresser K, Lutman CV, Fischer AH.

Mod Pathol. 2007 Dec;20(12):1263-8. Epub 2007 Sep 21.

PMID:
17885673
[PubMed - indexed for MEDLINE]
Free Article
14.

Merkel cell carcinoma expresses K homology domain-containing protein overexpressed in cancer similar to other high-grade neuroendocrine carcinomas.

Pryor JG, Simon RA, Bourne PA, Spaulding BO, Scott GA, Xu H.

Hum Pathol. 2009 Feb;40(2):238-43. doi: 10.1016/j.humpath.2008.07.009. Epub 2008 Oct 5.

PMID:
18835627
[PubMed - indexed for MEDLINE]
15.

Insulin-like growth factor II-messenger RNA-binding protein-3 and lung cancer.

Findeis-Hosey JJ, Xu H.

Biotech Histochem. 2012 Jan;87(1):24-9. doi: 10.3109/10520295.2011.591831. Epub 2011 Aug 15. Review.

PMID:
21838610
[PubMed - indexed for MEDLINE]
16.

KOC (K homology domain containing protein overexpressed in cancer): a novel molecular marker that distinguishes between benign and malignant lesions of the pancreas.

Yantiss RK, Woda BA, Fanger GR, Kalos M, Whalen GF, Tada H, Andersen DK, Rock KL, Dresser K.

Am J Surg Pathol. 2005 Feb;29(2):188-95.

PMID:
15644775
[PubMed - indexed for MEDLINE]
17.

Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma.

Zigeuner R, Tsybrovskyy O, Ratschek M, Rehak P, Lipsky K, Langner C.

Urology. 2004 Jun;63(6):1079-83.

PMID:
15183954
[PubMed - indexed for MEDLINE]
18.

Profiles of the 2 INK4a gene products, p16 and p14ARF, in human reference urothelium and bladder carcinomas, according to pRb and p53 protein status.

Le Frère-Belda MA, Gil Diez de Medina S, Daher A, Martin N, Albaud B, Heudes D, Abbou CC, Thiery JP, Zafrani ES, Radvanyi F, Chopin D.

Hum Pathol. 2004 Jul;35(7):817-24.

PMID:
15257544
[PubMed - indexed for MEDLINE]
19.

Cyclin-dependent kinase inhibitor P27(KIP1) is expressed preferentially in early stages of urothelial carcinoma.

Franke KH, Miklosi M, Goebell P, Clasen S, Steinhoff C, Anastasiadis AG, Gerharz C, Schulz WA.

Urology. 2000 Oct 1;56(4):689-95.

PMID:
11018640
[PubMed - indexed for MEDLINE]
20.

Utility of anti-L523S antibody in the diagnosis of benign and malignant serous effusions.

Hanley KZ, Facik MS, Bourne PA, Yang Q, Spaulding BO, Bonfiglio TA, Xu H.

Cancer. 2008 Feb 25;114(1):49-56.

PMID:
18098206
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk